Blog post
June 12, 2026

CGM and Diabetes Marketing in the GCC: Lessons from Accu-Chek SmartGuide and World Diabetes Day

Three years of World Diabetes Day campaigns, from 16 million reach to a mixed-reality CGM launch generating 1,100 qualified leads.

The GCC has one of the highest diabetes prevalence rates in the world, which makes World Diabetes Day the most important date on a diabetes brand's calendar and the most crowded. Three consecutive WDD campaigns for Roche Diabetes Care Middle East taught us how the category actually moves: 2023 reached 16 million, 2024 reached 50.9 million, and 2025 converted attention into 1,100 qualified leads for the Accu-Chek SmartGuide CGM launch at 13.5 million reach. The arc matters more than any single number.

Year one: earn the right to attention

The 2023 campaign built around food culture, because in the Gulf, diabetes lives at the dinner table. Leading with culinary culture instead of clinical fear gave the brand a way into conversations that product messaging could never open. Sixteen million reach proved the platform. The lesson: in health categories, culture is the door and the product is what you do after you are inside.

Year two: build a universe, not a campaign

The 2024 campaign tripled reach to 50.9 million by moving from a message to a world: culturally rooted characters that audiences across the GCC could recognise as their own. Characters scale in ways slogans cannot. They generate content rather than just carrying it, and they give a regulated brand a compliant vehicle for emotion. The lesson: in year two, stop renting attention and start building property.

Year three: convert the equity

The 2025 campaign launched the Accu-Chek SmartGuide CGM with mixed-reality creative and a lead engine underneath it. Reach was 13.5 million, deliberately narrower, and it produced 1,100 qualified leads. Two years of cultural equity meant the audience already trusted the brand when it finally asked for something. The lesson: conversion is a harvest. It only works if the seasons before it were planted.

What CGM brands should take from this

Continuous glucose monitoring is a behaviour-change product in a culture-bound category. The marketing has to move people from finger-prick habits to sensor trust, which is an emotional journey before it is a clinical one. Budget across years, not quarters. Build characters and platforms that compliance can love. And design the conversion year before you need it, so the data infrastructure is ready when the equity is.

Key takeaways

  • Three-year arc: 16 million reach, then 50.9 million, then 1,100 qualified leads at 13.5 million reach.
  • Year one earns attention through culture. Food is the door in Gulf diabetes communication.
  • Year two builds owned property: characters and worlds that scale beyond a single campaign.
  • Year three harvests: conversion works because the previous seasons were planted.
  • CGM is behaviour change. The emotional journey precedes the clinical one.

Sources

  • IDF Diabetes Atlas regional prevalence data.
  • Add Hype and Roche Diabetes Care Middle East WDD case studies, 2023 to 2025.

Add Hype has run World Diabetes Day for Roche across the GCC for three consecutive years. If your health brand needs a platform that compounds, write to us at hype@weaddhype.com.

Other posts